Our expert team at Suddenly Slimmer Med Spa in PHX can help
Heres how GLP-1 can support your journey toward better health and a more youthful, vibrant life: When you eat, your body naturally releases GLP-1 from specialized intestinal cells, signaling your pancreas to release insulin
Compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality
The FAERS database also revealed 41 reported cases for semaglutide with an ROR of 11.36 (95% CI, 8.33 to 15.49) and a PRR of 11.36 (95% CI, 8.32 to 15.47), suggesting a potential causal relationship between semaglutide and NAION [98]
TRIUMPH-1 Phase 3 trial results for retatrutide in obesity, Jastreboff AM, et al
Summary: Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) showing promising early weight-loss and metabolic data in Phase 2 trials, but it is not yet approved in the UK and carries notable side effects and safety uncertainties